raloxifene hydrochloride has been researched along with trifluoperazine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bern, HA; Chou, YC; Iguchi, T | 1 |
Bram, Y; Chen, S; Copertino, DC; Duarte, RRR; Han, Y; IƱiguez, LP; Marston, JL; Nixon, DF; Powell, TR; Schwartz, RE | 1 |
2 other study(ies) available for raloxifene hydrochloride and trifluoperazine
Article | Year |
---|---|
Effects of antiestrogens on adult and neonatal mouse reproductive organs.
Topics: Animals; Animals, Newborn; Body Weight; Clomiphene; Estrogen Antagonists; Female; Genitalia, Female; Genitalia, Male; Male; Mice; Mice, Inbred C57BL; Nafoxidine; Organ Size; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Trifluoperazine; Uterus; Vagina | 1992 |
Identifying FDA-approved drugs with multimodal properties against COVID-19 using a data-driven approach and a lung organoid model of SARS-CoV-2 entry.
Topics: Antiviral Agents; Atorvastatin; Cell Line; Coronavirus 3C Proteases; Coronavirus RNA-Dependent RNA Polymerase; COVID-19; COVID-19 Drug Treatment; Doxycycline; Drug Approval; Drug Repositioning; Gene Expression Regulation; Humans; Lung; Models, Biological; Molecular Docking Simulation; Organoids; Raloxifene Hydrochloride; SARS-CoV-2; Spike Glycoprotein, Coronavirus; Trifluoperazine; United States; United States Food and Drug Administration; Vesiculovirus; Virus Internalization | 2021 |